ReviewMolecular neurobiology2024

CNS-Active p38α MAPK Inhibitors for the Management of Neuroinflammatory Diseases: Medicinal Chemical Properties and Therapeutic Capabilities.

Mehdi Valipour et al.PubMed ↗Publisher ↗

No numbers read from the abstract.